Delta Point hires former AstraZeneca exec Michael Hickey

Thursday, March 7, 2013 01:40 PM

Michael Hickey, former vice president of U.S. sales at AstraZeneca and former president of AstraZeneca, Netherlands, has joined Delta Point of Malvern, Pa., as senior vice president of global leadership development.

Hickey has 30 years of experience in the industry in production, clinical research, marketing, sales and senior management in the U.S., Canada and Europe. 

He was president of IBA Molecular, North America, a radiopharmaceutical company. Prior to that, at AZ he led the launch of megabrands such as Crestor, Seroquel and Nexium.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs